Samuel Lawrence Aitken is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Education & Training
University at Buffalo, State University of New YorkPharmD, 2011
Publications & Presentations
PubMed
- 50 citationsOral Versus Aerosolized Ribavirin for the Treatment of Respiratory Syncytial Virus Infections in Hematopoietic Cell Transplant Recipients.Farnaz Foolad, Samuel L. Aitken, Terri Lynn Shigle, Amrita Prayag, Shashank S. Ghantoji
Clinical Infectious Diseases. 2019-05-02 - 24 citationsClonal Emergence of Invasive Multidrug-Resistant Staphylococcus epidermidis Deconvoluted via a Combination of Whole-Genome Sequencing and Microbiome Analyses.Xiqi Li, Cesar A. Arias, Samuel L. Aitken, Jessica Galloway Peña, Diana Panesso
Clinical Infectious Diseases. 2018-07-18 - 16 citationsCarbapenem versus Cefepime or Piperacillin-Tazobactam for Empiric Treatment of Bacteremia Due to Extended-Spectrum-β-Lactamase-Producing Escherichia coli in Patients w...Grace E. Benanti, Anne Rain T. Brown, Terri Lynn Shigle, Jeffrey J. Tarrand, Micah M. Bhatti
Antimicrobial Agents and Chemotherapy. 2019-01-29
Journal Articles
- Oral Versus Aerosolized Ribavirin for the Treatment of Respiratory Syncytial Virus Infections in Hematopoietic Cell Transplantation RecipientsSamuel L Aitken, Roy F Chemaly, Clinical Infectious Diseases
Office
1500 E Medical Center Dr
Ann Arbor, MI 48109Phone+1 734-232-0000
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
